Patient and Payer Considerations in Parkinson Disease Psychosis to Optimize Population Health Outcomes: A Multistakeholder Panel Discussion

This publication was sponsored by Acadia Pharmaceuticals Inc.

This clinical brief provides insights from a panel of stakeholders about Parkinson disease (PD) and the prevalence and care of PD psychosis (PDP). The experts also offer key information about PDP from the payer and clinical perspectives.